Search Results

Filter
  • 1-10 of  20 results for ""Vickaryous N""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Plasma proteomic profiles of UK Biobank participants with multiple sclerosis.

  • Authors : Jacobs BM; Centre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.; Department of Neurology, Royal London Hospital, London, UK.

Subjects: Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/pathology; Adult ; Humans

  • Source: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2024 Mar; Vol. 11 (3), pp. 698-709. Date of Electronic Publication: 2024 Jan 28.Publisher: Wiley Periodicals, Inc on behalf of American Neurological Association Country of Publication: United States NLM ID: 101623278 Publication Model:

Record details

×
Academic Journal

A phase 2a open-label clinical trial to determine the effect of famciclovir on EBV activity as measured by EBV shedding in the saliva of patients with multiple sclerosis.

  • Authors : Dobson R; Centre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University London, London, UK.; Department of Neurology, The Royal London Hospital, Barts Health NHS Trust, London, UK.

Subjects: Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/drug therapy ; Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/complications ; Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/drug therapy

  • Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2024 Jan; Vol. 30 (1), pp. 63-70. Date of Electronic Publication: 2023 Dec 22.Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccination.

  • Authors : Zaloum SA; Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.; Wood CH

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects

  • Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2023 Jul; Vol. 29 (8), pp. 979-989.Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print Cited Medium: Internet ISSN: 1477-0970

Record details

×
Academic Journal

Vitamin D genetic risk scores in multiple sclerosis.

  • Authors : Kuri A; Barts and The London School of Medicine and Dentistry, QMUL, London, UK.; Preventive Neurology Unit, Wolfson Institute of Population Health, Charterhouse Square, London, EC1M 6BW, UK.

Subjects: Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/epidemiology ; Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/genetics ; Vitamin D Deficiency*

  • Source: Journal of neurology [J Neurol] 2023 Feb; Vol. 270 (2), pp. 1030-1035. Date of Electronic Publication: 2022 Nov 05.Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0423161 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis.

  • Authors : Tallantyre EC; Division of Psychological Medicine and Clinical Neuroscience, School of Medicine, Cardiff University, United Kingdom; Department of Neurology, University Hospital of Wales, Cardiff, United Kingdom.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/drug therapy; Antibodies, Viral

  • Source: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2022 Aug; Vol. 64, pp. 103937. Date of Electronic Publication: 2022 Jun 04.Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

COVID-19 Vaccine Response in People with Multiple Sclerosis.

  • Authors : Tallantyre EC; Division of Psychological Medicine and Clinical Neuroscience, School of Medicine, Cardiff University, Cardiff, UK.; Department of Neurology, University Hospital of Wales, Cardiff, UK.

Subjects: Immunocompromised Host*; Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*therapeutic use ; COVID-19/COVID-19/COVID-19/*prevention & control

  • Source: Annals of neurology [Ann Neurol] 2022 Jan; Vol. 91 (1), pp. 89-100. Date of Electronic Publication: 2021 Nov 17.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7707449 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Remote testing of vitamin D levels across the UK MS population-A case control study.

  • Authors : Vickaryous N; Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Queen Mary University London, London, United Kingdom.; Jitlal M

Subjects: Dietary Supplements*; Multiple Sclerosis/Multiple Sclerosis/Multiple Sclerosis/*blood ; Vitamin D/Vitamin D/Vitamin D/*blood

  • Source: PloS one [PLoS One] 2020 Dec 30; Vol. 15 (12), pp. e0241459. Date of Electronic Publication: 2020 Dec 30 (Print Publication: 2020).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
  • 1-10 of  20 results for ""Vickaryous N""